Legence Corp. Form 8-K Summary
Business Context and Reporting Period
On January 2, 2026, Legence Corp. (the "Company") consummated the previously announced acquisition of The Bowers Group, Inc. ("Bowers"). The transaction was executed through the Company's wholly owned subsidiary, Legence Subsidiary Holdings, LLC. This filing reports the closing of the acquisition and related financing activities.
Key Financial Metrics and Transaction Details
- Total Consideration: Approximately $325 million in cash plus 2,551,672 shares of Class A common stock.
- Deferred Consideration: An additional $50 million payable on December 31, 2026, in cash or stock at the Company's discretion.
- Financing: The Company secured a new incremental term loan facility of $200 million under Amendment No. 12 to its Credit Agreement. This facility was drawn down in full on the closing date.
- Funding Sources: The cash portion of the acquisition was funded using a combination of cash on hand, borrowings under the existing revolving credit facility, and the full proceeds of the new $200 million term loan.
- Operating Metrics: The filing does not provide specific revenue, profit, cash flow, or margin data for the Company or the acquired entity.
Material Changes
The primary material change is the addition of Bowers as a wholly owned subsidiary of Legence Corp. Additionally, the Company's debt profile has changed with the addition of a $200 million incremental term loan. The Company issued 2,551,672 shares of unregistered Class A common stock to the sellers as part of the purchase price.
Outlook, Risks, and Contingencies
- Regulatory Compliance: The acquisition was subject to the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act), with the waiting period expiring on December 31, 2025.
- Future Obligations: The Company has a contingent obligation to pay $50 million in deferred consideration by December 31, 2026.
- Financial Reporting: Pro forma financial information and financial statements of the acquired business are not included in this filing and will be submitted via amendment within 71 calendar days.
- Debt Terms: The new incremental term loans carry terms identical to the Company's existing term loans.
Investor Verification Checklist
- Verify the final purchase price after customary post-closing adjustments.
- Review the upcoming pro forma financial statements (due within 71 days) to assess the impact of the acquisition on leverage and liquidity.
- Confirm the specific interest rates and covenants associated with the new $200 million incremental term loan.
- Monitor the Company's decision on the form of payment (cash vs. stock) for the $50 million deferred consideration.